Poll
Is biotechnology just a fancy way for big companies to patent life and charge us more?
As gene-editing technologies like CRISPR advance and patents on seeds and therapies multiply, the line between innovation and monopolization grows blurrier, especially amid rising healthcare costs. Cast your vote to share where you stand on this critical debate.
Options
Live results
Vote first to see results.
Emoji reactions
No reaction selected.
Comments
Please sign in to comment.
Share / embed
Quick info
- How do I vote in the "Is biotechnology just a fancy way for big companies to patent life and charge us more?" poll?
- Select one option on the page to cast your vote; results update with community votes in real time.
- Can I view results without voting?
- Yes. Use the "I don't know / Show results" option, or access the results summary after voting.
Similar polls
Up to 10 suggestions from the same category and shared tags, sorted by vote count; this poll is excluded.
From the same category
Basic Sciences and BiotechnologyThe same site category as this poll.
- Is learning basic biology still useful now that AI can answer everything?
- Would you switch from E. coli to yeast expression systems for higher protein yield?
- Can gene editing really fix our food supply as climate change worsens?
- Is CRISPR-based editing too reckless for human trials, or are ethical fears holding back a revolution?
- Is synthetic biology overhyped or the next big thing in basic sciences?
- Have peer-reviewed papers become a popularity contest for novel results rather than a reliable foundation for reproducible science?
- Do synthetic biology startups add real value, or mostly hype hoping for a patent sell-off?
- Should we embrace dangerous gain-of-function research or is the pandemic risk too high to justify it?
- Are "natural" biotech products safer, or is that just a marketing lie?
- Do you trust AI-generated drug candidates more than those from traditional screening methods?
TrendVersus.com · live data